<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 13451983
IT is a well established observation that Rauwolfia therapy causes an increase in body weight in some hypertensive subjects. Certain clinical observations have suggested that this weight increase might be the result of fluid retention. McGregor and Segel,1 Perera,2 Smirk and McQueen3 and Marley and Pare4 have described edema, breathlessness and raised venous pressure after Rauwolfia therapy for hypertension; Marley and Pare also reported a weight increase and a fall in hematocrit in nonhypertensive subjects on reserpine. Sarwer-Foner5 and Ferguson6 have noted edema in psychiatric patients given reserpine, and Greenblatt7 found that the edema of premenstrual tension became more pronounced . . .
Reserpine, Humans, Body Fluids
Reserpine, Humans, Body Fluids
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |